Literature DB >> 12163604

Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system.

Anthony N van den Pol1, Jon D Reuter, Justin G Santarelli.   

Abstract

Cytomegalovirus (CMV) has been suggested as the most prevalent infectious agent causing neurological dysfunction in the developing brain; in contrast, CMV infections are rare in the adult brain. One explanation generally given for the developmental susceptibility to the virus is that the developing immune system is too immature to protect the central nervous system from viral infection, but as the immune system develops it can protect the brain. We suggest an alternate view: that developing brain cells are inherently more susceptible to CMV infection, independent of the immune system. We used a recombinant mouse CMV that leads to green fluorescent protein expression in infected cells. Control experiments demonstrated a high correlation between the number of cells detected with the viral GFP reporter gene and with immunocytochemical detection of the virus. After intracerebral inoculation, the number of CMV-infected cells in neonatal brains was many times greater than in mature control or mature immunodepressed SCID mice, and the mortality rate of neonates was substantially greater than SCID or control adults. Parallel experiments with live brain slices inoculated in vitro, done in the absence of the systemic immune system, generated similar data, with immature hippocampus, hypothalamus, cortex, striatum, and cerebellum showing substantially greater numbers of infected cells (100-fold) than found in adult slices in these same regions. Interestingly, in the cerebellar cortex, CMV-infected cells were more prevalent in the postmitotic Purkinje cell layer than in the mitotic granule cell layer, suggesting a selective infection of some cell types not dependent on cell division. Together, these data support the view that CMV has an intrinsic preference for infection of developing brain cells, independent, but not mutually exclusive, of the developmental status of the systemic immune system in controlling CMV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163604      PMCID: PMC136989          DOI: 10.1128/jvi.76.17.8842-8854.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.

Authors:  R R Brutkiewicz; R M Welsh
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

2.  Glia-neuron intercellular calcium signaling.

Authors:  A C Charles
Journal:  Dev Neurosci       Date:  1994       Impact factor: 2.984

3.  Comparison of interleukin 2 and gamma-interferon production by peripheral blood mononuclear cells in response to cytomegalovirus after marrow transplantation.

Authors:  R A Bowden; S Dobbs; D Amos; J D Meyers
Journal:  Transplantation       Date:  1990-07       Impact factor: 4.939

4.  Physiologic and morphologic retinal changes induced by murine cytomegalovirus in BALB/c and severe combined immune deficient mice.

Authors:  A Mizota; D I Hamasaki; S S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-04       Impact factor: 4.799

5.  Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.

Authors:  R P Reynolds; R J Rahija; D I Schenkman; C B Richter
Journal:  Lab Anim Sci       Date:  1993-08

6.  Congenital cytomegalovirus infection and neonatal auditory screening.

Authors:  T Hicks; K Fowler; M Richardson; A Dahle; L Adams; R Pass
Journal:  J Pediatr       Date:  1993-11       Impact factor: 4.406

7.  Unusual cell specific expression of a major human cytomegalovirus immediate early gene promoter-lacZ hybrid gene in transgenic mouse embryos.

Authors:  R Kothary; S C Barton; T Franz; M L Norris; S Hettle; M A Surani
Journal:  Mech Dev       Date:  1991-08       Impact factor: 1.882

8.  Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient.

Authors:  K L Ho; C Gottlieb; R J Zarbo
Journal:  Clin Neuropathol       Date:  1991 May-Jun       Impact factor: 1.368

9.  Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.

Authors:  M Koedood; A Fichtel; P Meier; P J Mitchell
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice.

Authors:  R D Cardin; G B Abenes; C A Stoddart; E S Mocarski
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

View more
  24 in total

1.  The pathogenesis of spinal cord involvement in dengue virus infection.

Authors:  Jing An; De-Shan Zhou; Kazunori Kawasaki; Kotaro Yasui
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

2.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

3.  Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.

Authors:  Anthony N van den Pol; Guochao Mao; Anasuya Chattopadhyay; John K Rose; John N Davis
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain.

Authors:  Anthony N van den Pol; Michael D Robek; Prabhat K Ghosh; Koray Ozduman; Prasanthi Bandi; Matthew D Whim; Guido Wollmann
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

5.  CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain.

Authors:  Jon D Reuter; Jean H Wilson; Kimberly E Idoko; Anthony N van den Pol
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Immunometabolic phenotype of BV-2 microglia cells upon murine cytomegalovirus infection.

Authors:  Natalia Kučić; Valentino Rački; Kristina Jurdana; Marina Marcelić; Kristina Grabušić
Journal:  J Neurovirol       Date:  2019-04-25       Impact factor: 2.643

7.  Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonates.

Authors:  Carol A Wu; Sara A Paveglio; Elizabeth G Lingenheld; Li Zhu; Leo Lefrançois; Lynn Puddington
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

8.  Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain.

Authors:  Jon D Reuter; Daniel L Gomez; Jean H Wilson; Anthony N Van Den Pol
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Long-distance interferon signaling within the brain blocks virus spread.

Authors:  Anthony N van den Pol; Siyuan Ding; Michael D Robek
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

Review 10.  Treatment of perinatal viral infections to improve neurologic outcomes.

Authors:  William J Muller
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.